Clinical trial of Umifenovir proves successful in treating Covid
The trial of Umifenovir on 132 Covid patients showed that, if the proper dose is given twice daily for five days, the drug can effectively reduce viral load to zero in mild or moderate symptomatic and asymptomatic patients